3,5-Dinitro-4-propylamino-benzenesulfonamide

ID: ALA310237

Chembl Id: CHEMBL310237

Cas Number: 62409-47-6

PubChem CID: 478792

Max Phase: Preclinical

Molecular Formula: C9H12N4O6S

Molecular Weight: 304.28

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCNc1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-]

Standard InChI:  InChI=1S/C9H12N4O6S/c1-2-3-11-9-7(12(14)15)4-6(20(10,18)19)5-8(9)13(16)17/h4-5,11H,2-3H2,1H3,(H2,10,18,19)

Standard InChI Key:  IOJAESFEVURKSE-UHFFFAOYSA-N

Alternative Forms

Associated Targets(non-human)

Leishmania donovani (89745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania sp. (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 304.28Molecular Weight (Monoisotopic): 304.0478AlogP: 0.97#Rotatable Bonds: 6
Polar Surface Area: 158.47Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.39CX Basic pKa: CX LogP: 1.46CX LogD: 1.46
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.58Np Likeness Score: -1.48

References

1. Bhattacharya G, Salem MM, Werbovetz KA..  (2002)  Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin.,  12  (17): [PMID:12161141] [10.1016/s0960-894x(02)00465-1]
2. Goodarzi M, da Cunha EF, Freitas MP, Ramalho TC..  (2010)  QSAR and docking studies of novel antileishmanial diaryl sulfides and sulfonamides.,  45  (11): [PMID:20728249] [10.1016/j.ejmech.2010.07.060]

Source